Montelukast and Inhaled Nasal Steroid Tx in Adult Obstructive Sleep Apnea (OSA)

Completed · Phase 3 · Has a placebo group

Conditions studied: Obstructive Sleep Apnea

In brief

In children with mild apnea combined therapy with an inhaled nasal steroid and a medication that decreased nasal congestion (montelukast) was shown to be effective. We are testing to see if this combination works in adults with mild apnea as well.

Key facts

Study ID

NCT01089647

Run by

Romaker & Associates

People needed

34

Starts

2010-09-01

Expected to finish

2014-06-01

Last updated by the study team

2018-12-03

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age 18 - 100 years
• RDI between 5 - 15
• all races
• both sexes

You may not qualify if…

• craniofacial, syndromic, neurological abnormalities
• current or previous use of Singular, Rhinocort within last 6 months
• acute upper respiratory infections
• recent nasal trauma, nasal surgery, nasal septum perforation
• known immunodeficiency or under going immunosuppressant therapy
• current therapy with drugs that interact with Montelukast or Budesonide

Where it is running

• Romaker & Associates — Kansas City, Missouri, United States
• Romaker & Assoc — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.